Lawrence C. Best
No más puestos en curso
Perfil
Lawrence C.
Best is the founder and currently holds the position of Chairman at OXO Capital LLC, which was founded in 2007.
He is also currently the Chairman at NeoSync, Inc. and the Director at 4Tech Cardio Ireland Ltd.
Mr. Best previously held the position of Executive Chairman at Valtech Cardio Ltd.
and Cardiovalve Ltd.
He also served as a Director at Biogen MA, Inc. and Biogen, Inc. From 2003 to 2014, Mr. Best was an Independent Director at Haemonetics Corp.
and from 2009 to 2020, he held the same position at Myriad Genetics, Inc. He was a Director at Archemix Corp.
and Biogen Idec New Ventures, Inc. Mr. Best was also a Founding Director-Presidents Council at The General Hospital Corp.
He started his career as a Senior Partner at Ernst & Young LLP from 1981 to 1992.
Mr. Best obtained his undergraduate degree from Kent State University (Ohio).
Cargos activos de Lawrence C. Best
Empresas | Cargo | Inicio |
---|---|---|
4Tech Cardio Ireland Ltd.
4Tech Cardio Ireland Ltd. Medical SpecialtiesHealth Technology 4Tech Cardio Ireland Ltd. develops and manufactures surgical devices. The company was founded in 2011 and is headquartered in Waltham, MA. | Director/Board Member | - |
Antiguos cargos conocidos de Lawrence C. Best.
Empresas | Cargo | Fin |
---|---|---|
MYRIAD GENETICS, INC. | Director/Board Member | 04/12/2020 |
HAEMONETICS CORPORATION | Director/Board Member | 31/07/2014 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Director/Board Member | 31/12/2008 |
BOSTON SCIENTIFIC CORPORATION | Director of Finance/CFO | 01/01/2007 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/1992 |
Formación de Lawrence C. Best.
Kent State University (Ohio) | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
BOSTON SCIENTIFIC CORPORATION | Health Technology |
BIOGEN INC. | Health Technology |
HAEMONETICS CORPORATION | Health Technology |
MYRIAD GENETICS, INC. | Health Technology |
Empresas privadas | 8 |
---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | Commercial Services |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Finance |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
4Tech Cardio Ireland Ltd.
4Tech Cardio Ireland Ltd. Medical SpecialtiesHealth Technology 4Tech Cardio Ireland Ltd. develops and manufactures surgical devices. The company was founded in 2011 and is headquartered in Waltham, MA. | Health Technology |
Valtech Cardio Ltd.
Valtech Cardio Ltd. Medical SpecialtiesHealth Technology Valtech Cardio Ltd. develops devices for mitral valve repair and replacement. It specializes in the development of devices for mitral and tricuspid valve repair and replacement. The firm also offers full in-house development, manufacturing and clinical research capabilities, and patent applications. The company was founded by Amir Gross and Yossi Gross in March 2005 and is headquartered in Or Yehuda, Israel. | Health Technology |
Cardiovalve Ltd.
Cardiovalve Ltd. Medical SpecialtiesHealth Technology Part of Venus Medtech (Hangzhou), Inc., Cardiovalve Ltd. is an Israeli medical device company that specializes in developing the Cardiovalve transcatheter system. The private company is based in Or Yehuda, Israel. The system is designed to replace regurgitating mitral and tricuspid valves using a transfemoral-transseptal approach. The CEO of the company is Amir Gross. Cardiovalve was acquired by Athena Medtech Holding Ltd. on January 25, 2022 for $83.98 million. | Health Technology |
- Bolsa de valores
- Insiders
- Lawrence C. Best